Guidelines

What is pandel cream used for?

What is pandel cream used for?

This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Hydrocortisone probutate reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium-strength corticosteroid.

How do you use pandel cream?

Apply a thin film to the affected skin area. Gently rub PANDEL into your skin until it disappears. Tell your healthcare provider if your symptoms do not improve after 2 weeks of treatment. Do not bandage, cover, or wrap the treated area unless your healthcare provider tells you to.

Who is pandel?

Pandel (hydrocortisone probutate cream) is a corticosteroid cream used to treat skin inflammations such as allergic reactions, eczema, or psoriasis. Pandel is available in generic form.

Are there any side effects to taking Pandel?

Cream, 0.1%. Each gram of Pandel contains 1 mg of hydrocortisone probutate in a cream base. None. Pandel can produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for glucocorticosteroid insufficiency. This may occur during or after withdrawal of treatment.

How often should I apply Pandel to my Skin?

Pandel ® (hydrocortisone probutate) Cream, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 18 years of age or older. Apply a thin film of Pandel to the affected area once or twice a day depending on the severity of the condition.

Which is hydrocortisone probutate in Pandel cream?

Pandel(hydrocortisone probutate) Cream, 0.1% contains hydrocortisone probutate, a synthetic corticosteroid. The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and anti-pruritic agents.

How old do you have to be to take Pandel?

Indications and Usage for Pandel. Pandel ® (hydrocortisone probutate) Cream, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 18 years of age or older.